Influence of Estradiol-17beta on Progesterone and Estrogen Receptor mRNA Expression in Porcine Follicular Granulosa Cells during Short-Term, In Vitro Real-Time Cell Proliferation.
Sylwia CiesiółkaJoanna BudnaKarol JopekArtur BryjaWiesława KrancAdrian ChachułaSylwia BorysMarta Dyszkiewicz KonwińskaAgnieszka ZiółkowskaPaweł AntosikDorota BukowskaKlaus P BrüssowMałgorzata BruskaMichał NowickiMaciej ZabelBartosz KempistyPublished in: BioMed research international (2016)
Progesterone (P4) and estradiol (E2) play a significant role in mammalian reproduction. Our study demonstrated that separated porcine cumulus cells (CCs) and/or granulosa cells (GCs) might proliferate in vitro during short-term, real-time primary culture. The GCs were analyzed according to gene expression of the progesterone receptor (nuclear form) (pgr), progesterone receptor membrane component 1 (pgrmc1), and estrogen-related receptor beta 3 (esrrb3) in relation to two housekeeping genes: actb and pbgd. GCs were cultivated in medium with the E2. Both pgr/actb and pgr/pbgd revealed higher expression between 24 and 168 h of IVC of prolonged E2 treatment and at 48 h of IVC after acute E2 administration. The pgrmc1/actb and pgrmc1/pbgd displayed increased expression after prolonged E2 treatment between 24 and 120 h of IVC. The highest level of esrrb3/actb at 120 and 144 h, as well as esrrb3/pbgd at 120 h, in untreated controls as compared to the hormone-stimulated group, was observed. We suggest that E2 significantly influences the upregulation of pgr, pgrmc1, and esrrb3 expression in porcine GCs during real-time cell proliferation. Since esrrb3 expression is stimulated by E2 in both an acute and prolonged manner, estradiol may be recognized as a potential estrogen receptor agonist in GCs.
Keyphrases
- estrogen receptor
- poor prognosis
- cell proliferation
- induced apoptosis
- gene expression
- cell cycle arrest
- binding protein
- inferior vena cava
- endoplasmic reticulum stress
- signaling pathway
- pi k akt
- type diabetes
- liver failure
- pulmonary embolism
- metabolic syndrome
- risk assessment
- insulin resistance
- drug induced
- skeletal muscle
- genome wide identification